Jun 20, 2025

Chance Rain Showers 51°
Seattle, WA

SYSTEMIC DELIVERY, LOCAL ACTIVITY

Press Releases

Bonum Therapeutics to Participate in Panel on Conditionally Active Biologics at BIO 2025

Chief Business Officer Neela Patel, Ph.D., will discuss the promise and challenges of these next-generation drugs, which have the potential to overcome shortcomings of current state-of-the-art therapies, including ADCs and bispecifics…

Bonum Therapeutics Appoints Samuel C. Blackman, MD, PhD, to its Board of Directors

We are delighted to welcome Sam Blackman to the Bonum Therapeutics team. His judgment and his deep experience in the clinical development of novel immune-oncology agents will benefit…

Bonum Therapeutics to Present Posters and a Short Talk on its Novel Platform for Generating Conditionally Activated Targeted Therapies at Keystone Conference

“We are excited about the success of our platform technology with multiple conditionally active target/effector combinations, and we are particularly encouraged by the rapid progress of our lead program…”

In the news